6533b872fe1ef96bd12d2a27

RESEARCH PRODUCT

The risk of Second Primary Cancer (SPC) in patients with Splenic Marginal Zone Lymphoma (SMZL)

Stefano De CantisAnna Maria Taormina

subject

http://hdl.handle.net/10447/25760